Benjamin Looker's Securities Transactions at Esperion Therapeutics, Inc.

Benjamin Looker, an officer at Esperion Therapeutics, Inc., has reported securities transactions involving the company's common stock. On October 15, 2025, Looker acquired 1,248 shares through restricted stock vesting as part of compensation. These shares are set to be sold on October 17, 2025, with an aggregate market value of $3,275.38. Additionally, Looker sold 1,304 shares on July 17, 2025, for $1,469.35 and 6,267 shares on September 17, 2025, for $17,575.80. The sales include amounts necessary to cover tax obligations resulting from the settlement of vested equity awards. The transactions were facilitated by Fidelity Brokerage Services LLC.